Savant Capital’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,759
Closed -$587K 219
2014
Q4
$587K Buy
2,759
+470
+21% +$93.5K 0.22% 82
2014
Q3
$408K Hold
2,289
0.17% 102
2014
Q2
$387K Buy
2,289
+21
+0.9% +$3.27K 0.17% 106
2014
Q1
$282K Sell
2,268
-1,147
-34% -$140K 0.13% 132
2013
Q4
$379K Sell
3,415
-7
-0.2% -$669 0.19% 93
2013
Q3
$310K Buy
3,422
+1
+0% +$90 0.17% 97
2013
Q2
$288K Buy
+3,421
New +$355K 0.17% 100

Other funds holding AGN

Savant Capital's AGN Position: Q1 2015 in Review

Savant Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,759 shares — an estimated $587K sold.

Savant Capital first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $587K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Savant Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Savant Capital sold 2,759 Allergan Inc shares in Q1 2015, an estimated $587K.
  • Savant Capital first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Savant Capital's Allergan Inc position peaked at $587K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Savant Capital's 13F filing for Q1 2015, filed 13 May 2015.